214 related articles for article (PubMed ID: 31713298)
1. Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis.
Srour MK; Gao B; Dadmanesh F; Carlson K; Qu Y; Deng N; Cui X; Giuliano AE
Breast J; 2020 May; 26(5):904-910. PubMed ID: 31713298
[TBL] [Abstract][Full Text] [Related]
2. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis.
Srour MK; Qu Y; Deng N; Carlson K; Mirocha J; Gao B; Dadmanesh F; Cui X; Giuliano AE
Breast J; 2021 May; 27(5):432-440. PubMed ID: 33464691
[TBL] [Abstract][Full Text] [Related]
3. Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer.
Tan W; Xie X; Huang Z; Chen L; Tang W; Zhu R; Ye X; Zhang X; Pan L; Gao J; Tang H; Zheng W
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):288-297. PubMed ID: 31858816
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
[TBL] [Abstract][Full Text] [Related]
6. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
7. Reduced risk of axillary lymphatic spread in triple-negative breast cancer.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Breast Cancer Res Treat; 2015 Jan; 149(1):229-36. PubMed ID: 25488719
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration.
Yu Y; Cui N; Li HY; Wu YM; Xu L; Fang M; Sheng Y
BMC Cancer; 2016 Oct; 16(1):808. PubMed ID: 27756234
[TBL] [Abstract][Full Text] [Related]
9. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
[TBL] [Abstract][Full Text] [Related]
10. Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era.
Liang Y; Chen X; Tong Y; Zhan W; Zhu Y; Wu J; Huang O; He J; Zhu L; Li Y; Chen W; Shen K
World J Surg Oncol; 2019 Feb; 17(1):37. PubMed ID: 30786903
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
[TBL] [Abstract][Full Text] [Related]
12. Integrative 3' Untranslated Region-Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple-Negative Breast Cancer.
Wang L; Hu X; Wang P; Shao ZM
Oncologist; 2019 Jan; 24(1):22-30. PubMed ID: 30082491
[TBL] [Abstract][Full Text] [Related]
13. HER2 expression is a strong independent predictor of nodal metastasis in breast cancer.
Ahmed AR
J Egypt Natl Canc Inst; 2016 Dec; 28(4):219-227. PubMed ID: 27756653
[TBL] [Abstract][Full Text] [Related]
14. Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.
Liao N; Li C; Cao L; Chen Y; Ren C; Chen X; Mok H; Wen L; Li K; Wang Y; Zhang Y; Li Y; Lv J; Cao F; Luo Y; Li H; Wu W; Balch CM; Giuliano AE
Breast Cancer; 2023 Jan; 30(1):77-87. PubMed ID: 36129636
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
[TBL] [Abstract][Full Text] [Related]
16. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between extranodal invasion in axillary lymph node metastasis and prognosis of breast cancer patients].
Zhang LL; Ma L; Geng CZ; Jia Y; Wang XL; Liu YP
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):525-529. PubMed ID: 28810291
[No Abstract] [Full Text] [Related]
18. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.
Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R
Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]